HomeCompareBTBFX vs JNJ

BTBFX vs JNJ: Dividend Comparison 2026

BTBFX yields 12.32% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BTBFX wins by $25.0K in total portfolio value
10 years
BTBFX
BTBFX
● Live price
12.32%
Share price
$57.37
Annual div
$7.07
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.1K
Annual income
$2,654.88
Full BTBFX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BTBFX vs JNJ

📍 BTBFX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBTBFXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BTBFX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BTBFX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BTBFX
Annual income on $10K today (after 15% tax)
$1,047.08/yr
After 10yr DRIP, annual income (after tax)
$2,256.65/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, BTBFX beats the other by $1,553.04/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BTBFX + JNJ for your $10,000?

BTBFX: 50%JNJ: 50%
100% JNJ50/50100% BTBFX
Portfolio after 10yr
$32.5K
Annual income
$1,741.33/yr
Blended yield
5.35%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BTBFX
No analyst data
Altman Z
0.8
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BTBFX buys
0
JNJ buys
0
No recent congressional trades found for BTBFX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBTBFXJNJ
Forward yield12.32%3.36%
Annual dividend / share$7.07$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$45.1K$20.0K
Annual income after 10y$2,654.88$827.78
Total dividends collected$19.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BTBFX vs JNJ ($10,000, DRIP)

YearBTBFX PortfolioBTBFX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,932$1,231.85$10,676$355.77+$1.3KBTBFX
2$14,141$1,373.67$11,407$389.39+$2.7KBTBFX
3$16,652$1,521.47$12,198$426.53+$4.5KBTBFX
4$19,492$1,674.47$13,056$467.62+$6.4KBTBFX
5$22,688$1,831.83$13,987$513.12+$8.7KBTBFX
6$26,269$1,992.72$14,998$563.56+$11.3KBTBFX
7$30,265$2,156.29$16,098$619.52+$14.2KBTBFX
8$34,705$2,321.71$17,295$681.69+$17.4KBTBFX
9$39,622$2,488.16$18,599$750.82+$21.0KBTBFX
10$45,051$2,654.88$20,022$827.78+$25.0KBTBFX

BTBFX vs JNJ: Complete Analysis 2026

BTBFXStock

The fund will invest in a diversified portfolio of stocks, bonds and money market instruments, with at least 20% of the fund's assets invested in each of the following categories: (i) domestic and foreign equity securities, such as common stock and (ii) fixed-income securities, such as U.S. government and agency securities, corporate bonds, money market funds, and cash.

Full BTBFX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BTBFX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BTBFX vs SCHDBTBFX vs JEPIBTBFX vs OBTBFX vs KOBTBFX vs MAINBTBFX vs ABBVBTBFX vs MRKBTBFX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.